PBAC Public Summary Documents - July 2019 meeting

1 November 2019 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2019 PBAC ...

Read more →

PBAC Public Summary Documents - May 2019 meeting

1 November 2019 - The Public Summary Documents from the May 2019 PBAC intracycle meeting are now available. ...

Read more →

Annual performance statistics report: July 2018 to June 2019

21 October 2019 - At 30 June 2019 there were 88,788 therapeutic goods on the ARTG, including 31,987 new products added ...

Read more →

ICER releases updated draft evidence report on rheumatoid arthritis therapies

11 October 2019 - Public comment period extended through 8 November 2019; public meeting now to take place on 9 December ...

Read more →

High health care costs suggest review is needed: report

8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...

Read more →

ICER releases draft evidence report on rheumatoid arthritis therapies

26 September 2019 - Public comment period now open until 24 October 2019; requests to make oral comment during public ...

Read more →

ICER publishes evidence report on additive cardiovascular disease therapies

12 September 2019 - Pricing of rivaroxaban and icosapent ethyl aligns well with treatments’ benefits for patients; expert roundtable will discuss ...

Read more →

ICER releases draft evidence report on diabetes therapies

11 September 2019 - Public comment period now open until 8 October 2019; Requests to make oral comment during public meeting ...

Read more →

Bad diagnosis: health care system muddled, lacking leadership major report finds

3 September 2019 - The review is being led by former prime minister Helen Clark's chief of staff, Heather Simpson. ...

Read more →

Academics and consumer groups protest FDA plan to summarise review documents

29 August 2019 - A Food and Drug Administration proposal to substitute detailed reviews of new drugs written by specific ...

Read more →

Australian Public Assessment Reports for prescription medicines

28 August 2019 - TGA is reviewing the operation of transparency measures and are considering activities to increase transparency of ...

Read more →

Extension to feedback for public consultation - standardised redactions of PBAC Public Summary Documents

19 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers and ...

Read more →

ICER releases draft evidence report on additive cardiovascular disease therapies

24 July 2019 - Public comment period now open until 20 August 2019; requests to make oral comment during public ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting

19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are ...

Read more →

Drug Utilisation Sub-Committee outcome statement

17 July 2019 - The outcome statement from the June 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →